Jack A Elias

17PUBLICATIONS
117CO-AUTHORS
Predictive and prognostic markersMolecular targetsAutoimmunityAllergyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 27, 2026
Targeting Lysyl Oxidase-like 2: A Therapeutic Strategy for Idiopathic Pulmonary Fibrosis with a Novel Indolizine Derivative.

|Feb 26, 2026
CHI3L1 Expression in Chordoma: Implications for Immunotherapeutic Intervention.

Beatrice Campilan, Christian Godinez, Jonathan Arditi

|Dec 25, 2025
Switch-like methylation of functional pathways distinguishes COPD and idiopathic pulmonary fibrosis.

Katherine H Shutta, Yichen Huang, Vincent L Carey

|Dec 03, 2025
Dysregulated alveolar type 2 epithelial cell proteostasis promotes fibrogenic macrophage migration inhibitory factor-CD74 signaling.

Sang-Hun Kim, Jessica Nouws, Jannik Ruwisch

|Jul 18, 2025
CHI3L1/YKL-40 signaling inhibits neurogenesis in models of Alzheimer's disease.

Xin Yang, Wei Jiang, Yuhan Li

|Sep 18, 2024
Chitinase 3-like-1 Inhibits Innate Antitumor and Tissue Remodeling Immune Responses by Regulating CD47-SIRPα- and CD24-Siglec10-Mediated Phagocytosis.

Bing Ma, Suchitra Kamle, Takayuki Sadanaga

Pageof 3

Frequent Collaborators

13 joint publications

Chun-Geun Lee

4 joint publications

Suchitra Kamle

2 joint publications

Myung Hyun Sohn

2 joint publications

Changyong Tang